Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
Perspective Therapeutics, a NYSE American-listed company developing alpha-emitting radiopharmaceutical therapies for various cancers, announced it will release its second quarter 2026 financial results and provide a business update on August 10, 2026. The company is advancing clinical-stage drug candidates targeting neuroendocrine tumors, melanoma,…